Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Blood biomarkers may help avoid unnecessary surgery in boys with testicle issues

NCT ID NCT07315737

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at tiny molecules in the blood called miRNAs to see if they could help doctors tell apart two similar conditions in boys: undescended testicles (which need surgery) and retractile testicles (which usually get better on their own). Researchers took blood samples from 28 boys and measured three specific miRNAs. The goal was to find a simple test that could reduce unnecessary surgeries and improve care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

28 people

The number who actually took part.

Started

Mar 2022

Finished

Apr 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Control group: Healthy kids with both testes in scrotum. Undescended testis group: Kids with unilateral palpable undescended testis or bilateral palpable testes. Recractile testis group: Kids under monitorisation for unilateral retractile testis or bilateral retractile testes.

Ages

3 months to 18 years

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Palpable (unilateral or bilateral) undescended testis cases * Retractile testis cases; physician examinations were performed in three positions (supine, semisupine, standing), followed by a 1-month parental examination (twice daily). * Healty kids less than 18 years old with palpable two testes palpable in scrotum. Exclusion Criteria: * Prior inguinal/scrotal surgery * Defective datasets * Unsuitable serum samples

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MIRAS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ordu University

    Ordu, Altınordu, 52200, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.